FB2026_03 , released September 17, 2026
Human Disease Model Report: schizophrenia, dopamine ontogeny hypothesis
Open Close
General Information
Name
schizophrenia, dopamine ontogeny hypothesis
FlyBase ID
FBhh0000829
Disease Ontology Term
Parent Disease
OMIM
Overview

The dopamine ontogeny hypothesis of schizophrenia integrates two aspects of the development of schizophrenia for which there is substantial evidence, (1) that dopamine signaling is affected and (2) that adverse events occurring during either gestation or at birth can increase disease risk; it postulates that transient dysregulation of the dopaminergic system during fetal brain development increases the likelihood of developing the disorder in adulthood. It has also been suggested that developing dopaminergic neurons and circuitry are particularly vulnerable to an array of adverse environmental factors during fetal and neonatal development.

Work in Drosophila has characterized the impact of perturbations during later brain development, since the fly brain continues to develop past the pupal stage and into the first several days of adulthood. By manipulating the activity of dopaminergic neurons, it was found that a transient increase of dopamine activity during the late pupal stage permanently alters behavior, brain activity, and sleep patterns in adult animals. Transient reduction in the expression of dopamine receptor Dop1R1 or Dop1R2 during the late pupal stage also results in permanent behavioral changes.

[updated Jul. 2018 by FlyBase; FBrf0222196]

Disease Summary Information
Parent Disease Summary: schizophrenia, susceptibility to
Symptoms and phenotype

See also 'Schizophrenia: Symptoms, causes, and treatments' (http://www.medicalnewstoday.com/articles/36942.php).

Schizophrenia is a psychosis, a disorder of thought and sense of self. Although it affects emotions, it is distinguished from mood disorders in which such disturbances are primary. Similarly, there may be mild impairment of cognitive function, and it is distinguished from the dementias in which disturbed cognitive function is considered primary. Schizophrenia often develops in young adults who were previously normal, and is characterized by a constellation of symptoms including hallucinations and delusions (psychotic symptoms) and symptoms such as severely inappropriate emotional responses, disordered thinking and concentration, erratic behavior, as well as social and occupational deterioration (Andreasen, 1995; pubmed:7637483). [from MIM:181500; 2017.04.18]

Specific Disease Summary: schizophrenia, dopamine ontogeny hypothesis
OMIM report
Human gene(s) implicated
Symptoms and phenotype

The dopamine ontogeny hypothesis of schizophrenia proposes that transient dysregulation of the dopaminergic system during brain development increases the likelihood of developing the disorder in adulthood (Kesby et al., 2013 pubmed:23882183; Eyles et al., 2012, pubmed:22832818).

Fetal hypoxia, hypoxia-related obstetric complications, and hypoxia during the early neonatal period are major environmental risk factors shown to be associated with an increased risk for later psychopathology; these events can result in selective long-term disturbances of the dopaminergic systems that persist in adulthood (Giannopoulou et al., 2018; pubmed:29858855).

Genetics
Cellular phenotype and pathology
Molecular information
External links
    Disease synonyms
    Ortholog Information
    Human gene(s) in FlyBase
      Other mammalian ortholog(s) used
        D. melanogaster Gene Information (0)
        Other Genes Used: Viral, Bacterial, Synthetic (0)
          Summary of Physical Interactions (0 groups)
          Alleles Reported to Model Human Disease (Disease Ontology) (0 alleles)
          Alleles Representing Disease-Implicated Variants
          Genetic Tools, Stocks and Reagents
          Sources of Stocks
          Contact lab of origin for a reagent not available from a public stock center.
          Bloomington Stock Center Disease Page
          Related mammalian, viral, bacterial, or synthetic transgenes
          Allele
          Transgene
          Publicly Available Stocks
          Selected Drosophila transgenes
          Allele
          Transgene
          Publicly Available Stocks
          RNAi constructs available
          Allele
          Transgene
          Publicly Available Stocks
          Selected Drosophila classical alleles
          Allele
          Allele class
          Mutagen
          Publicly Available Stocks
          References (4)